Medrad is collaborating with the University of South Florida (USF) in Tampa to study the impact of automated FDG administration on the workflow for PET imaging procedures.
Clinicians at the Moffitt Cancer Center in Tampa will use Medrad’s Intego PET infusion system to measure and infuse patient-specific FDG doses while industrial engineers from USF gather and analyze workflow data. The company said the goal is to compare manual infusion and automated infusion and to determine the time, cost and labor savings resulting from automated FDG infusion process improvements.
Accord to the Warrendale, Pa.-based Medrad, the Intego PET infusion system eliminates manual dose preparation and handling – and by extension, the radiation exposure to the technologist inherent in manual preparation. Its dose-on-demand capability allows the prescribed dose to be administered when the clinician and patient are ready, and allows the clinician to respond to patient delays, schedule changes and add-on patients.